Heyholder
‹ Activism Filings

Genesystem Co., Ltd Absorbs a wholly owned instrument-making subsidiary with no new shares issued

Genesystem Co., Ltd· Material Event Report

AI summary · Not investment advice

Genesystem Co., Ltd will absorb a wholly owned subsidiary, an instrument and relay maker, without issuing new shares, so its share count stays the same.

Key facts

Merger ratio
1.0000000 : 0.0000000No new shares issued
Merger counterparty
A wholly owned subsidiaryMaker of switchboard instruments, protective relays and transformers
Merger date
Dec 18, 2026
Merger method
The company absorbs its subsidiaryThe company survives; the subsidiary is dissolved
Merger type
Small-scale mergerApproved by the board instead of a shareholders' meeting
Purpose of merger
Integrate business capabilities, improve efficiency and secure long-term growth
Appraisal rights
Not granted (small-scale merger)
Board resolution date
Oct 15, 2026

Commentary

AI commentary · Not investment advice

What happened

Genesystem will absorb its wholly owned subsidiary, which makes measuring instruments, relays and transformers. After the merger, only Genesystem remains and the subsidiary is dissolved. The company said the aim is to combine business capabilities and run more efficiently.

In the company's terms

Because Genesystem already owns all of the subsidiary, the merger ratio is 1.0000000 : 0.0000000. No new shares are issued, so the share count and largest shareholder stay the same. The subsidiary posted 2025 revenue of KRW 24.0 billion and net income of KRW 383.6 million.

What changes for shareholders

As a small-scale merger, it is approved by the board rather than a shareholders' meeting. Shareholders therefore have no right to ask the company to purchase their shares (appraisal rights). However, if holders of 20% or more of shares object between 2026.10.30 and 2026.11.13, it cannot proceed this way. The merger date is 2026.12.18, with registration expected on 2026.12.21.

Comments

No comments yet

Comments from shareholders will appear here.